救济疗法获得新的RLF-TD011化合物的欧洲专利,获得专有权。 Relief Therapeutics gets European patent for new compound RLF-TD011, securing exclusive rights.

救济治疗机构已收到欧洲专利局对其化合物RLF-TD011的专利赠款。 Relief Therapeutics has received a patent grant from the European Patent Office for their compound RLF-TD011. 这一发展是公司的一个重要里程碑,因为这一发展在一定时期内为他们提供了在欧洲大院的专属权。 This development is a significant milestone for the company, as it provides them with exclusive rights to the compound in Europe for a set period. RLF-TD011是一种治疗性化合物,但公告中没有提供有关其使用的具体细节。 RLF-TD011 is a therapeutic compound, though specific details about its use were not provided in the announcement.